Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Pascual, Aurélie ^a,b   Basco, Leonardo K ^b   Baret, Eric ^a,b   Amalvict, Rémy ^a,b   Travers, Dominique ^a,b   Rogier, Christophe ^a,b   Pradines, Bruno ^a,b,c  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c Centre National de Reference du Paludisme   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; BENFLUMETOL; CARBON DIOXIDE; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; DOXYCYCLINE; MEFLOQUINE; OXYGEN; PYRIMETHAMINE; QUININE; ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; ATMOSPHERIC GENERATOR; CARBON DIOXIDE MEASUREMENT; CONTROLLED STUDY; CULTURE MEDIUM; GENERATOR; IC 50; IN VITRO STUDY; INCUBATOR; INFECTION RESISTANCE; NONHUMAN; OXYGEN CONCENTRATION; PARASITE CULTIVATION; PLASMODIUM FALCIPARUM; STRAIN DIFFERENCE; COMPARATIVE STUDY; DRUG EFFECT; DRUG SENSITIVITY; EVALUATION; METABOLISM; METHODOLOGY;

ANTIMALARIALS; CARBON DIOXIDE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 78651373186     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-8     Document Type: Article

References (42)

1. Les résistances aux médicaments antipaludiques. J Le Bras L Musset J Clain, Med Maladies Infect 2006 36 401 405 10.1016/j.medmal.2006.05. 005 (Pubitemid 44425394)
2. Artemisinin-based combination treatment of falciparum malaria. F Nosten NJ White, Am J Trop Med Hyg 2007 77 181 192 18165491
3. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. RT Eastman DA Fidock, Nat Rev Microbiol 2009 7 864 874 19881520
4. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
5. Changes in the treatment responses to artesunate-mefloquine on the Northwestern border of Thailand during 13 years of continuous deployment. VI Carrara J Zwang EA Ashley RN Price K Stepniewska M Barends A Brockman T Anderson R McGready L Phaiphun S Proux M van Vugt R Hutagalung KM Lwin AP Phyo P Preechapornkul M Imwong S Pukrittayakamee P Singhasivanon NJ White K Nosten, PlosOne 2009 4 4451
6. Artemisinin resistance in Plasmodium falciparum malaria. AM Dondorp F Nosten P Yi D Das AP Phyo J Tarning KM Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwrong K Chotivanish P Lim T Herdman SS An S Yeung P Singhasivanon NPJ Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
7. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. WO Rogers R Sem T Tero P Chim P Lim S Muth D Socheat F Ariey C Wongsrichanalai, Malar J 2009 8 10 19138388 10.1186/1475-2875-8-10
8. The rationale and plan for creating a World Antimalarial Resistance Network (WARN). CH Sibley KI Barnes CV Plowe, Malar J 2007 6 118 17822531 10.1186/1475-2875-6-118 (Pubitemid 47525010)
9. A network to monitor antimalarial drug resistance: a plan for moving forward. CH Sibley KI Barnes WM Watkins CV Plowe, Trends Parasitol 2008 24 43 48 2008 10.1016/j.pt.2007.09.008 18042432
10. Susceptibility of Plasmodium falciparum to antimalarial drugs. Reports on global monitoring 1996-2004. WHO, WHO/HTM/MAL/2005.110 Geneva: WHO 2005
11. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. RE Desjardins CJ Canfield JD Haynes JD Chulay, Antimicrob Agents Chemother 1979 16 710 718 394674
12. In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin. World Health Organisation, WHO/CTD/MAL/97.20 Rev 2 2001 Geneva: WHO 2001
13. Drug sensitivity of Plasmodium falciparum. An in-vitro microtechnique. KH Rieckmann GH Campbell LJ Sax JE Mrema, Lancet 1978 1 22 23 10.1016/S0140- 6736(78)90365-3 74500
14. Field evaluation of drug resistance in malaria. In vitro micro-test. WH Wernsdorfer, Acta Trop 1980 37 222 227 6106357
15. Stage-specific activity of potential antimalarial compounds measured in vitro by flow cytometry in comparison to optical microscopy and hypoxanthine uptake. CE Contreras MA Rivas J Dominguez J Charris M Palacios NE Bianco I Blanca, Mem Inst Oswaldo Cruz 2004 99 179 184 10.1590/S0074-02762004000200011 15250472
16. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. JB Bacon C Latour C Lucas O Colina P Ringwald S Picot, Antimicrob Agents Chemother 2007 51 1172 1178 17220424 10.1128/AAC.01313-06 (Pubitemid 46586790)
17. Performance and reliability of the SYBR green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. MA Rason TA Randriantsoa H drianantenaina A Ratsimbasoa D Menard, Trans R Soc Trop Med Hyg 2008 102 346 351 10.1016/j.trstmh.2008.01.021 18321546
18. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. H Noedl WH Wernsdorfer RS Miller C Wongsrichanalai, Antimicrob Agents Chemother 2002 46 1658 1664 12019072 10.1128/AAC.46.6.1658-1664.2002 (Pubitemid 34535179)
19. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. H Noedl J Bronnert K Yingyuen B Attlmayr H Kollaritsch M Fukuda, Antimicrob Agents Chemother 2005 49 3575 3577 16048989 10.1128/AAC.49.8.3575-3577.2005 (Pubitemid 41060624)
20. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. P Druilhe A Moreno C Blanc PH Brasseur P Jacquier, Am J Trop Med Hyg 2001 64 233 241 11463109
21. Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. H Kaddouri A Djimdé S Dama A Kodio M Tekete V Hubert A Koné H Maiga O Yattara B Fofana B Sidibe CPO Sangaré O Doumbo J Le Bras, Int J Parasitol 2008 38 791 798 10.1016/j.ijpara.2007.12.002 18249407
22. Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. LK Basco, Am J Trop Med Hyg 2004 70 474 480 15155978
23. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. B Pradines A Spiegel C Rogier A Tall J Mosnier T Fusai JF Trape D Parzy, Am J Trop Med Hyg 2000 62 82 85 10761729
24. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. B Pradines P Hovette T Fusai HL Atanda E Baret P Cheval J Mosnier A Callec J Cren R Amalvict JP Gardair C Rogier, J Clin Microbiol 2006 44 2404 2408 16825356 10.1128/JCM.00623-06 (Pubitemid 44092404)
25. In vitro evaluation of the sensitivity of Plasmodium falciparum to chloroquine using the deli-microtest in region of Dakar, Senegal. T Dieng IB Bah PM Ndiaye I Diallo BM Diop P Brasseur S Mboup D Wirth O Ndir, Med Trop 2005 65 580 583
26. Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay. S Briolant P Parola M Madamet-Torrentino E Baret J Mosnier J Delmont D Parzy P Minodier C Rogier B Pradines, Malar J 2007 6 44 17437625 10.1186/1475-2875-6-44 (Pubitemid 46652084)
27. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. AA Divo TG Geary JB Jensen, Antimicrob Agents Chemother 1985 27 21 27 3885844
28. In vitro susceptibility test of Plasmodium falciparum using a portable thermostat and CO2 gas generator. Q Lin T Onda S Kano G Masuda M Suzuki, J Jpn Assoc Inf Dis 1999 73 1099 1103
29. Plasmodium falciparum: Effective use of the CO2-NaHCO3 buffer system for evaluating chloroquine resistance. S He A Saito-Ito K Tanabe T Matsumura, Exp Parasitol 2000 94 121 124 10.1006/expr.1999.4471 10673348
30. Synchronization of Plasmodium falciparum erythrocytic stages in culture. C Lambros JP Vanderberg, J Parasitol 1979 65 418 420 10.2307/3280287 383936
31. Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. H Bogreau F Renaud H Bouchiba P Durand SB Assi MC Henry E Garnotel B Pradines T Fusai B Wade E Adehossi P Parola MA Kamil O Puijalon C Rogier, Am J Trop Med Hyg 2006 74 953 959 16760503
32. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. M Henry I Diallo J Bordes S Ka B Pradines B Diatta PS M'Baye M Sane M Thiam PM Gueye B Wade JE Touze JM Debonne C Rogier T Fusai, Am J Trop Med Hyg 2006 75 146 151 16837722
33. Plasmodium falciparum chemoresistance. The situation in Africa in 1989. J Le Bras P Ringwald, Med Trop 1990 50 161 162
34. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. LK Basco J Le Bras, Ann Trop Med Parasitol 1994 88 137 144 8067809
35. Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area of Senegal. I Hatin JF Trape F Legros J Bauchet J Le Bras, Bull WHO 1992 70 363 367 1638665
36. In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. LK Basco Le Bras, Am J Trop Med Hyg 1993 48 120 125 8427380
37. In vitro activity of pyrimethamine, cycloguanil and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. LK Basco O Ramiliarisoa J Le Bras, Am J Trop Med Hyg 1994 50 193 199 8116812 (Pubitemid 24079426)
38. Plasmodium falciparum: microaerophilic requirements in human red blood cells. LW Scheibel SH Ashton W Trager, Exp Parasitol 1979 47 410 418 10.1016/0014-4894(79)90094-8 36286
39. Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum. J Krungkrai D Burat S Kudan S Krungkrai P Prapunwattana, Southeast Asian J Trop Med Public Health 1999 30 636 642 10928353
40. Culture of Plasmodium falciparum: the role of pH, glucose, and lactate. MD Jensen M Conley LD Helstowski, J Parasitol 1983 69 1060 1067 10.2307/3280864 6371212
41. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulates oxidant stress. J Krungkrai Y Yuthavong, Trans R Soc Trop Med Hyg 1987 81 710 714 10.1016/0035-9203(87)90003-4 3329778
42. Generation of free radicals and enhancement of hemin-induced membrane damage by a catechol iron chelator in Plasmodium falciparum. B Pradines F Ramiandrasoa T Fusai A Hammadi M Henry S Briolant E Orlandi-Pradines H Bogreau J Mosnier E Baret G Kunesch J Le Bras C Rogier, J Biol Sc 2005 5 463 471 10.3923/jbs.2005.463.471